Hospital Medicine: Management Of The Hospitalized Adult Patient 2022 - InPerson

Hospital Medicine: Management Of The Hospitalized Adult Patient is organized by American Medical Seminars (AMS), Inc. and will be held from Apr 04 - 07, 2022 at Hyatt Regency Sarasota, Sarasota, Florida, United States of America.

Presented by:
Vandana Y. Bhide, M.D., F.A.C.P., F.A.A.P., A.B.I.H.M. - Dr. Bhide is a clinical assistant professor at Creighton University School of Medicine and the University of Arizona College of Medicine. She is currently the Medical Director of Advisory Services at Abrazo West Hospital in Phoenix, Arizona and a supplemental hospitalist at Mayo Clinic Arizona. Previously, Dr. Bhide was the Chief Hospitalist at Dignity St. Joseph’s Hospital and Medical Center in Phoenix, where she was a resident advisor, member of the clinical competency committee, and the director of the quality improvement curriculum. Prior to coming to Phoenix, Dr. Bhide was an assistant professor in Mayo College of Medicine and worked in the division of hospital internal medicine at Mayo Clinic Florida. She was also the director of Medical Grand Rounds, and core faculty and resident advisor for the internal medicine residency program at Mayo Clinic Florida. Dr. Bhide received her Bachelor of Science and Medical Degree at University of Wisconsin, and she did a residency in internal medicine and pediatrics at Duke University Medical Center.

David A. Horowitz, M.D. - Professor of Clinical Medicine, Perelman School of Medicine at the University of Pennsylvania; Associate Chief Medical Officer, University of Pennsylvania Health System; Philadelphia, PA

Ganesan Murali, M.D. - Attending Physician, Division of Pulmonary, Critical Care and Sleep Medicine, Lehigh Valley Health Care Network, Allentown, PA

Arshad A. Wani, M.D. - Associate Professor of Medicine, Perelman School of Medicine, University of Pennsylvania; Director, Respiratory Care and Principal Instructor, Point of Care Ultrasound Education; Attending Physician, Division of Pulmonary, Allergy, and Critical Care Medicine, Hospital of the University of Pennsylvania-Penn Presbyterian, Philadelphia, PA

Learning Objectives:
Day 1:
Septic Shock. 
Upon completion of this session, the participant should be able to: GL,COMP
• Define shock and differentiate the various types of shock.
• Develop and apply the concept of sepsis management bundles.
• Formulate and manage the early resuscitation of septic shock, vasopressor use and monitoring.
• Specify the current controversies in management of septic shock based on SCCM/Survival Sepsis Campaign Guidelines.
Critical Care Cases - A Primary Care Review.   
Upon completion of this session, the participant should be able to: COMP
• Pulmonary complications in Patients with Chronic Liver Disease. Discuss the pathophysiology of pleural effusion, hypoxemia and porto-pulmonary hypertension in patients with cirrhosis, Describe the management of pulmonary complications of cirrhosis, Review other complications of patients with cirrhosis in critical care.
• Management of Hypercapnic respiratory failure. Recognize clinical features of patients with hypercapnic respiratory failure, Describe the workup of hypercapnia, Review the treatment of hypercapnic respiratory failure.
• Management of Pulmonary edema in ICU, Detect pulmonary edema in the ICU, Differentiate cardiogenic versus non-cardiogenic types, Formulate a plan for the management of ARDS.
Approach to the Management of Stroke. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Develop a strategy to assess the common presentations of stroke/TIA.
• Utilize current initial treatment strategies appropriately.
• Develop a strategy to stratify the risk of stroke.
• Develop a secondary prevention plan.
Approach to the Management of Chest Pain. 
Upon completion of this session, the participant should be able to: GL,COMP
• Evaluate the complaint in the context of history, physical exam, and EKG findings.
• Develop a strategy to use cardiac biomarkers in the evaluation of ACS.
• Use recent research studies and guidelines to develop an approach to the patient with chest pain.
Pneumonia. 
Upon completion of this session, the participant should be able to: EBM,COMP
• Differentiate the presentation of various cases of pneumonia and management.
• Distinguish the different pathogens that cause pneumonia.
• Apply evidence-based recommendations for prevention of pneumococcal pneumonia.
• Plan the approach to health care associated pneumonia.

Day 2:
Approach to the Management of Diabetes in the Hospitalized Patient. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Develop a diabetes treatment strategy that identifies and reaches a target glucose.
• Develop a diabetes treatment strategy that integrates the issues of chronic management.
• Develop a diabetes treatment strategy that utilizes insulin effectively.
Strategies to Address the Issue of Preventable Hospital Readmissions.   
Upon completion of this session, the participant should be able to: EBM,COMP
• Identify the factors which contribute to increase risk of readmission.
• Stratify the risk for readmission utilizing evidence-based tools.
• Develop a transition of care strategy to reduce the likelihood of a preventable readmission.
COPD – Overview of Patient Management. 
Upon completion of this session, the participant should be able to: GL,COMP
• Appraise the definition and integrate the pathophysiology of COPD.
• Assess the clinical management of various issues regarding COPD.
• Treat acute exacerbations and outpatient management including long-term oxygen and pharmacologic treatment based on ATS/ACCP Guidelines.
• Evaluate the need of referral for surgical and newer treatments for emphysema.
Pulmonary Cases - A Primary Care Review. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Identify and properly evaluate sleep apnea and excessive daytime sleepiness.
• Specify the various causes of hemoptysis and develop an appropriate plan for management.
• Apply the evidence-based recommendations of pulmonary embolism including thrombolysis or appropriate referral for vena caval filters.
Bronchial Asthma: An Update. 
Upon completion of this session, the participant should be able to: GL,COMP
• Appraise the pathophysiology of this inflammatory disease.
• Develop a stepwise approach to treatment of asthma and management of status asthmaticus.
• Differentiate the patient who is not responding and specify indications for subspecialty referral.

Day 3:
Pleural Diseases: Effusions and Pneumothorax. 
Upon completion of this session, the participant should be able to: GL,COMP
• Determine the etiology of various pleural effusions by means of cases.
• Formulate the investigation and management of pleural effusions.
• Detect the presentation of pneumothorax.
• Develop the clinical approach to management of pneumothorax using the ACCP Delphi Guidelines.
Pulmonary Cases - Challenges for the PCP.   
Upon completion of this session, the participant should be able to: GL,COMP
• Develop a differential diagnosis and approach to a patient with a non-resolving infiltrate.
• Assess the causes and determine the evaluation of solitary lung nodule.
• Evaluate idiopathic pulmonary fibrosis and employ current management using the ATS/ERS Guidelines.
Systolic and Diastolic Heart Failure. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Appropriately manage decompensated heart failure in hospitalized patients.
• Assess the indications for positive inotropic agents and ultrafiltration in systolic heart failure.
• Distinguish the treatment of systolic versus diastolic heart failure, as per the 2013 ACCF/AHA Guidelines for heart failure management.
Atrial Fibrillation in the Hospitalized Patient. 
Upon completion of this session, the participant should be able to: GL,COMP
• Assess and evaluate treatment options for atrial fibrillation with rapid ventricular response, as per the 2010 HFSA Guidelines.
• Employ appropriate anticoagulation strategies for atrial fibrillation.
• Distinguish the advantages of rhythm versus rate control treatment strategies, 2014 ACC/AHA Guidelines for atrial fibrillation management.
• Determine the possible underlying causes of CHF exacerbations.
Challenging Infections: MRSA and C. difficile. 
Upon completion of this session, the participant should be able to: GL,COMP
• Assess and apply appropriate treatment strategies for different types of methicillin resistant staph aureus infections.
• Employ rational use and relate the precautions of newer antibiotics when treating resistant bacteria.
• Distinguish Guideline based treatment of Clostridium difficile infections.

Day 4:
Hospital Delirium. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Interpret changes in the updated 2012 American College of Chest Physicians Evidence-Based Guidelines for Antithrombotic Therapy.
• Assess restrictive red blood cell transfusion strategy as recommended by American Association of Blood Banks (AABB) guidelines.
• Evaluate clinical factors that make patients more prone to hospital and postoperative delirium.
• Employ evidence-based strategies to treat delirium in hospitalized patients.
Direct Oral Anticoagulants.   
Upon completion of this session, the participant should be able to: EBM,COMP
• Differentiate the advantages and disadvantages of commonly used anticoagulants. .
• Employ evidence-based anticoagulation bridging regimens.
• Assess the approved indications for various anticoagulation agents.
• Apply the evidence-based indications for anticoagulation in hospitalized patients.
Update in Perioperative Medicine. 
Upon completion of this session, the participant should be able to: EBM,GL,COMP
• Appraise pre-operative cardiac risk stratification and management strategies, as per the ACC/AHA Risk Clinical Predictors.
• Determine the role of non-invasive stress testing, echocardiography, coronary angiography and the use of biomarkers to assess peri-operative cardiac risk, as per the ACC/AHA (2014) Perioperative CV Evaluation Guidelines.
• Relate the indications for beta blockers, statins and aspirin in the peri-operative period.
• Evaluate the bleeding risks of commonly prescribed medications and OTC supplements taken pre-operatively.
Non-Invasive Ventilation and Oxygenation in Respiratory Failure. 
Upon completion of this session, the participant should be able to: GL,COMP
• Review the indications for NIV in acute respiratory failure.
• Understand the benefits and risks of NIV.
• Discuss the strategies for initiation of NIV and monitoring response.
• Discuss the use of NIV on the wards, outside of the ICU setting.
• Briefly review NIV use in COVID-19 patients.
Critical Care Cases - Challenges for the PCP. 
Upon completion of this session, the participant should be able to: GL,COMP
• Detect acute renal failure in the ICU and employ appropriate management using the International Consensus Guidelines.
• Detect and assess hypertensive emergencies in the ICU and prescribe appropriate management.